213 related articles for article (PubMed ID: 25279684)
21. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of compliance therapy on drug attitude among schizophrenic patients: a systematic review.
Chang YT; Lee LL
JBI Database System Rev Implement Rep; 2015 Aug; 13(7):213-40. PubMed ID: 26455856
[TBL] [Abstract][Full Text] [Related]
23. In response to the Commentary to our systematic review 'Does adherence therapy improve medication adherence among patients with schizophrenia?'.
Hegedüs A; Kozel B
Int J Ment Health Nurs; 2015 Aug; 24(4):373-4. PubMed ID: 26245521
[No Abstract] [Full Text] [Related]
24. Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.
Czobor P; Van Dorn RA; Citrome L; Kahn RS; Fleischhacker WW; Volavka J
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1158-66. PubMed ID: 26004980
[TBL] [Abstract][Full Text] [Related]
25. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
Chang YT; Tao SG; Lu CL
Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
[TBL] [Abstract][Full Text] [Related]
27. Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia.
Na E; Yim SJ; Lee JN; Kim JM; Hong K; Hong MH; Han H
Psychiatry Clin Neurosci; 2015 May; 69(5):298-304. PubMed ID: 25600955
[TBL] [Abstract][Full Text] [Related]
28. Medication Adherence Decisions in Patients With Schizophrenia.
Kikkert MJ; Dekker J
Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
[TBL] [Abstract][Full Text] [Related]
29. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
Beebe LH; Smith K; Phillips C
Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
[TBL] [Abstract][Full Text] [Related]
30. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.
Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
Schizophr Bull; 2013 Nov; 39(6):1242-51. PubMed ID: 24072808
[TBL] [Abstract][Full Text] [Related]
31. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
[TBL] [Abstract][Full Text] [Related]
32. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
33. Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
Bernardo M; Cañas F; Herrera B; García Dorado M
Rev Psiquiatr Salud Ment; 2017; 10(3):149-159. PubMed ID: 27291833
[TBL] [Abstract][Full Text] [Related]
34. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
35. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
36. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.
Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
Arch Gen Psychiatry; 2012 Mar; 69(3):265-73. PubMed ID: 22393219
[TBL] [Abstract][Full Text] [Related]
37. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
38. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
Vassileva I; Milanova V; Asan T
Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
40. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla).
Stentzel U; van den Berg N; Schulze LN; Schwaneberg T; Radicke F; Langosch JM; Freyberger HJ; Hoffmann W; Grabe HJ
BMC Psychiatry; 2018 May; 18(1):155. PubMed ID: 29843676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
